Dr Farnham studied her PhD at Macquarie University, where she focused on the role of PACAP in cardiovascular centres of the brain. In late 2013, she moved to HRI to join the High Blood Pressure Group. In 2018 she was promoted to Unit Leader and has since gone on to establish the Cardiovascular Neuroscience Group.
Her current research into sleep apnoea and epilepsy has produced two important studies that highlight PACAP as an important protective modulator of sympathetic activity during seizures, and resulted in two publications in the Journal of Neuroscience. Dr Farnham has also received substantial funding to investigate the role of PACAP in central cardiovascular control, highlighting the importance and potential of this research.
Her innovative techniques, coupled with comprehensive investigations into important cardiovascular questions, provide Dr Farnham the opportunity to further develop an area of research that is unique in Australia.